Congressional Cannabis Caucus Celebrates President Biden Signing Bipartisan Marijuana Research Reform
Congressional Cannabis Caucus Celebrates President Biden Signing Bipartisan Marijuana Research Reform
The Medical Marijuana and Cannabidiol Research Expansion Act is the first standalone federal marijuana reform law enacted since the adoption of the Controlled Substances Act in 1971.
WASHINGTON, D.C.—Today, Cannabis Caucus Co-Chairs Earl Blumenauer (D-OR), Barbara Lee (D-CA), Dave Joyce (R-OH), and Brian Mast (R-FL) released the following statement in celebration of President Biden’s signing of the Medical Marijuana and Cannabidiol Research Expansion Act:
“For decades, the federal government has stood in the way of science and progress—peddling a misguided and discriminatory approach to cannabis. Today marks a monumental step in remedying our federal cannabis laws. The Medical Marijuana and Cannabidiol Research Expansion Act will make it easier to study the impacts and potential of cannabis.
“Research is foundational for the path forward on cannabis policy. Research is essential to better understand the therapeutic benefits of cannabis that have the potential to help millions of Americans struggling with chronic pain, PTSD, multiple sclerosis, anxiety disorders and more.
“We celebrate the enactment of this critical and long-overdue legislation, and we know there is much more to do to remedy the ongoing harms of the failed war on drugs. Our caucus will continue working to reimagine the federal government’s approach to cannabis and enact further reforms. In the coming weeks, we are committed to passing subsequent bipartisan, common-sense proposals like the SAFE Banking package, the Veterans Equal Access Act, the PREPARE Act, and the Veterans Medical Marijuana Safe Harbor Act.”